These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34214412)

  • 21. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.
    Mueller SR; Walley AY; Calcaterra SL; Glanz JM; Binswanger IA
    Subst Abus; 2015; 36(2):240-53. PubMed ID: 25774771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
    Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
    Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
    [No Abstract]   [Full Text] [Related]  

  • 25. Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients.
    Jakubowski A; Pappas A; Isaacsohn L; Castillo F; Masyukova M; Silvera R; Holaday L; Rausch E; Farooq S; Veltri KT; Cunningham CO; Bachhuber MA
    Subst Abus; 2019; 40(1):61-65. PubMed ID: 30475162
    [No Abstract]   [Full Text] [Related]  

  • 26. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overdose Education and Naloxone Distribution Program Attendees: Who Attends, What Do They Know, and How Do They Feel?
    Heavey SC; Burstein G; Moore C; Homish GG
    J Public Health Manag Pract; 2018; 24(1):63-68. PubMed ID: 28257406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use.
    Sisson ML; Azuero A; Chichester KR; Carpenter MJ; Businelle MS; Shelton RC; Cropsey KL
    Drug Alcohol Depend; 2023 Aug; 249():110815. PubMed ID: 37336007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telephone-based opioid overdose education and naloxone distribution (OEND) pharmacy consult clinic.
    Szydlowski EM; Caruana SS
    Subst Abus; 2018; 39(2):145-151. PubMed ID: 31032747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overdose Education and Naloxone Distribution Within Syringe Service Programs - United States, 2019.
    Lambdin BH; Bluthenthal RN; Wenger LD; Wheeler E; Garner B; Lakosky P; Kral AH
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1117-1121. PubMed ID: 32817603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concerns that an opioid antidote could "make things worse": Profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale.
    Winograd RP; Werner KB; Green L; Phillips S; Armbruster J; Paul R
    Subst Abus; 2020; 41(2):245-251. PubMed ID: 31170030
    [No Abstract]   [Full Text] [Related]  

  • 32. "I'm not going to lay back and watch somebody die": a qualitative study of how people who use drugs' naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention.
    Kesich Z; Ibragimov U; Komro K; Lane K; Livingston M; Young A; Cooper HLF
    Harm Reduct J; 2023 Nov; 20(1):166. PubMed ID: 37946233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
    Pizzicato LN; Johnson CC; Viner KM
    Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
    [No Abstract]   [Full Text] [Related]  

  • 34. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
    Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
    Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. School-based interventions for reducing disciplinary school exclusion: a systematic review.
    Valdebenito S; Eisner M; Farrington DP; Ttofi MM; Sutherland A
    Campbell Syst Rev; 2018; 14(1):i-216. PubMed ID: 37131379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.
    Snooks H; Benger J; Bell F; Black S; Dixon S; Emery H; Evans BA; Fuller G; Hoskins R; Hughes J; Jones J; Jones M; Johnston S; Long J; Moore C; Parab R; Pilbery R; Sampson FC; Watkins A
    Health Technol Assess; 2024 Oct; 28(74):1-69. PubMed ID: 39487686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.
    Pauly JB; Vartan CM; Brooks AT
    Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural Appalachia.
    Macmadu A; Gurka KK; Linn HI; Smith GS; Feinberg J
    Subst Use Misuse; 2023; 58(2):163-170. PubMed ID: 36546533
    [No Abstract]   [Full Text] [Related]  

  • 39. Feasibility and acceptability of online opioid overdose education and naloxone distribution: Study protocol and preliminary results from a randomized pilot clinical trial.
    Sisson ML; Azuero A; Chichester KR; Carpenter MJ; Businelle MS; Shelton RC; Cropsey KL
    Contemp Clin Trials Commun; 2023 Jun; 33():101131. PubMed ID: 37091508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.